MARGARET KELLAR: Open Payments
NPI 1124644802 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 80 payments from 13 companies in 2025. Trend: 2023 $1,378 · 2024 $1,299 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $518 |
| Neurocrine BioSciences, Inc. | 12 | $366 |
| Lundbeck LLC | 11 | $161 |
| Otsuka America Pharmaceutical, Inc. | 11 | $151 |
| Corium, LLC | 8 | $116 |
| Vanda Pharmaceuticals Inc. | 4 | $102 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| ABBVIE INC. | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
Products named: CAPLYTA, INGREZZA, REXULTI, Azstarys, FANAPT, Auvelity, VRAYLAR, COBENFY.
Industry payments across AL — which companies pay providers there.
